pramipexole has been researched along with melatonin in 5 studies
| Studies (pramipexole) | Trials (pramipexole) | Recent Studies (post-2010) (pramipexole) | Studies (melatonin) | Trials (melatonin) | Recent Studies (post-2010) (melatonin) |
|---|---|---|---|---|---|
| 1,103 | 219 | 517 | 23,268 | 1,451 | 9,627 |
| Protein | Taxonomy | pramipexole (IC50) | melatonin (IC50) |
|---|---|---|---|
| Myeloperoxidase | Homo sapiens (human) | 3 | |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | 3.3323 | |
| Metabotropic glutamate receptor 1 | Rattus norvegicus (Norway rat) | 0.0004 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0005 | |
| Melatonin receptor type 1A | Homo sapiens (human) | 0.0025 | |
| Melatonin receptor type 1B | Homo sapiens (human) | 0.0035 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Gugger, JJ; Wagner, ML | 1 |
| Coburn, KL; Doonan, SM; Lauterbach, EC; Mendez, MF; Shillcutt, SD; Victoroff, J | 1 |
| Auerbach, SH; Aurora, RN; Casey, KR; Chowdhuri, S; Karippot, A; Kristo, DA; Maganti, RK; Morgenthaler, TI; Ramar, K; Zak, RS | 1 |
| Amos, LB; Collins, MM; D'Andrea, LA; Grekowicz, ML; Kuhn, EM; Norins, NA; Olstad, JD | 1 |
2 review(s) available for pramipexole and melatonin
| Article | Year |
|---|---|
Rapid eye movement sleep behavior disorder.
Topics: Anticonvulsants; Antiparkinson Agents; Benzothiazoles; Clonazepam; Comorbidity; Dopamine Agonists; GABA Modulators; Humans; Melatonin; Parkinson Disease; Pramipexole; REM Sleep Behavior Disorder | 2007 |
Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Antipsychotic Agents; Benzodiazepines; Benzothiazoles; Brain; Clonazepam; Desipramine; Dibenzothiazepines; Dopamine Agonists; Humans; Lithium Carbonate; Maprotiline; Melatonin; Neurodegenerative Diseases; Neuroprotective Agents; Olanzapine; Parkinson Disease; Pramipexole; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Valproic Acid | 2010 |
3 other study(ies) available for pramipexole and melatonin
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Best practice guide for the treatment of REM sleep behavior disorder (RBD).
Topics: Benzothiazoles; Central Nervous System Depressants; Clonazepam; Dopamine Agonists; GABA Modulators; Humans; Melatonin; Pramipexole; REM Sleep Behavior Disorder | 2010 |
Treatment of pediatric restless legs syndrome.
Topics: Adolescent; Amines; Analgesics; Anticonvulsants; Antioxidants; Benzothiazoles; Child; Child, Preschool; Clonidine; Cyclohexanecarboxylic Acids; Dopamine Agonists; Drug Therapy, Combination; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Indoles; Iron; Male; Melatonin; Mental Disorders; Pediatrics; Polysomnography; Pramipexole; Restless Legs Syndrome; Retrospective Studies; Sleep Wake Disorders; Treatment Outcome | 2014 |